Steven Karera

Steven Karera

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in JMIR Human Factors
Verified
Journal Article
Open access
BTBosun Tijani
Bosun Tijani
UIUchenna Igbokwe
Uchenna Igbokwe
TFTemi Filani
Temi Filani
AAAdefemi Adewemimo
Adefemi Adewemimo
LALola Ameyan
Lola Ameyan
Eric Osamudiamwen AigbogunEric Osamudiamwen Aigbogun
Eric Osamudiamwen Aigbogun
Background: A significant cause of postpartum hemorrhage (PPH) is access to and delivery of maternal health care services. Several multisectoral strategies have been deployed to address the challenges with little success, thereby necessitating the use of human-centered design (HCD) to enhance health care delivery, particularly in PPH management. Objective: This study aims to develop facility-level solutions for optimizing uterotonic supply chain systems and health service delivery in PPH management through an HCD approach in selected Nigerian states. Methods: The research used a four-phase HCD methodology: (1) co-research, (2) co-design, (3) co-refinement, and (4) implementation. However, this paper focused on the first 3 phases. In the co-research phase, 203 interviews were conducted, involving 80 pregnant women and nursing mothers, 97 health care workers, and 26 key stakeholders. Additionally, 33 sites were observed across a 3-level continuum of care. Interviews and focus group discussions revealed insights into the distribution of health workers and observed PPH cases, alongside knowledge and administration of uterotonics. Data analysis was carried out using three key steps: (1) identifying key themes from the collected data, (2) developing insight statements that encapsulate these themes, and (3) translating each insight statement into actionable design opportunities. Results: About 150 ideas were produced and translated into 12 solution prototypes in the co-design phase. Progressive refinement following feedback from 140 stakeholders led to the selection of three final solutions: (1) implementing a referral linkage system to improve the transportation of pregnant women to nearby health facilities, (2) increasing demand for antenatal care services among pregnant women and their families, and (3) delivering a comprehensive uterotonic logistics management program for streamlined uterotonic storage and management. Conclusions: This approach aligns with global health trends advocating for HCD integration in health care programming and aims to empower local champions to drive sustainable improvements in maternal health outcomes. Judicious implementation of the developed prototypes across the states can strengthen clinical care and potentially reduce maternal health service delivery gaps.

4 November 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OAOlufemi Samuel Amoo
Olufemi Samuel Amoo
FAFunmi Adewara
Funmi Adewara
BTBosun Tijani
Bosun Tijani
TOTochukwu Ifeanyi Onuigbo
Tochukwu Ifeanyi Onuigbo
AIAmaka Stephanie Ikemefuna
Amaka Stephanie Ikemefuna
BSBabatunde Salako
Babatunde Salako
The first case of COVID-19 in Nigeria was recorded on February 27, 2020, being an imported case by an Italian expatriate, to the country. Since then, there has been steady increase in the number of cases. However, the number of cases in Nigeria is low in comparison to cases reported by other countries with similar large populations, despite the poor health system prevailing in the country. This has been mainly attributed to the low testing capacity in Nigeria among other factors. Therefore, there is a need for innovative ways to increase the number of persons testing for COVID-19. The aim of the study was to pilot a nasopharyngeal swab self-sample collection model that would help increase COVID-19 testing while ensuring minimal person-to-person contact being experienced at the testing center. 216 participants took part in this study which was carried out at the Nigerian Institute of Medical Research between June and July 2020. Amongst the 216 participants, 174 tested negatives for both self-collected samples and samples collected by Professionals, 30 tested positive for both arms, with discrepancies occurring in 6 samples where the self-collected samples were positive while the ones collected by the professionals were negative. The same occurred in another set of 6 samples with the self-collected samples being negative and the professional—collected sample coming out positive, with a sensitivity of 83.3% and a specificity of 96.7%. The results of the interrater analysis are Kappa = 0.800 (95% CI, 0.690 to 0.910) which implies an outstanding agreement between the two COVID-19 sampling methods. Furthermore, since p< 0.001 Kappa (k) coefficient is statistically different from zero, our findings have shown that self-collected samples can be reliable in the diagnosis of COVID-19.

1 January 2026 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
GRGallican N. Rwibasira
Gallican N. Rwibasira
JKJean Claude Kwizera
Jean Claude Kwizera
SKSteven Karera
Steven Karera
Tafadzwa DzinamariraTafadzwa Dzinamarira
Tafadzwa Dzinamarira
CHCharles Holmes
Charles Holmes
TGTracy R. Glass
Tracy R. Glass
Background: Adolescents and young adults living with HIV (AYALHIV) in sub‐Saharan Africa have lower viral load (VL) suppression (VLS) rates than older adults. Rwanda lacks national‐level evidence on predictors of VLS in this age group. This study assessed demographic and clinical determinants of VLS among AYALHIV aged 15–24 years on antiretroviral therapy (ART), using national case‐based surveillance (CBS) data. Methods: We conducted a retrospective cohort analysis of AYALHIV enrolled in Rwanda’s CBS system who initiated ART between January 2019 and December 2025 and had a documented VL at least six months after ART initiation. The primary outcome, VLS, was defined as VL ≤ 1000 copies/mL. Modified Poisson regression with robust, facility‐clustered standard errors was used to estimate prevalence ratios (PRs); missing covariate data were addressed using multiple imputation ( m = 20), pooled using Rubin’s rules. Results: A total of 4140 participants across 458 health facilities were included. Most were female (88%) and aged 20–24 years (90.7%); 91.6% were initiated on a dolutegravir‐based regimen, 98.7% demonstrated good adherence, and overall, 96.1% achieved VLS. In multivariable analysis, good adherence was the only factor independently associated with VLS, corresponding to a 70% higher prevalence of suppression relative to bad/moderate adherence (adjusted PR = 1.70; 95% CI: 1.33–2.19; p < 0.001). Conclusion: VLS among AYALHIV aged 15–24 years engaged in Rwanda’s HIV care program is high, exceeding the UNAIDS 95% target. Country HIV programs should prioritize adherence‐focused interventions and proactively address underlying barriers to adherence in order to sustain optimal treatment outcomes in this population.

1 August 2025 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Open access
EREric Remera
Eric Remera
FCFrédérique Chammartin
Frédérique Chammartin
SNSabin Nsanzimana
Sabin Nsanzimana
SMSamuel S. Malamba
Samuel S. Malamba
GRGallican N. Rwibasira
Gallican N. Rwibasira
HBHeiner C. Bucher
Heiner C. Bucher
Introduction: Rwanda has initiated recency testing alongside existing HIV testing services of provider-initiated testing, partner notification services (PNSs), and of prevention of mother-to-child HIV transmission. We aimed to determine characteristics of the newly diagnosed population using a nationwide cohort. Methods: We included all newly diagnosed patients with HIV aged 15 and above who consented to recency testing and assessed patient- and health center–related predictors of recent HIV infection using multivariable logistic regression models. Results: We obtained data from 485 of 565 health facilities in Rwanda that introduced PNS and recency testing alongside preexisting testing services. From October 2018 to February 2024, 8940 individuals consented to HIV recency testing. Among them, 537 (6.0%) were recently infected. The odds of detecting a recent HIV infection increased by 1% for each month of experience in PNS. Patient-related factors associated with recent infections included female sex, younger age (15–24 years), residing in southern or northern provinces compared with the western province, and self-reported sex with a known HIV-infected person or unprotected sex outside of a relationship in the last 12 months. Conclusions: Only 6% of newly diagnosed HIV infections were characterized as recent. Public health interventions targeting younger females may assist in reducing new infections in this group.